Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06548945
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-08-08
Brief Title:
A Phase I Study of GZR18 Injection in ObeseOverweight Subjects
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Randomized Double-Blind Placebo-Controlled Dose-escalation Phase I Study to Evaluate the Safety Tolerability Pharmacokinetics and Pharmacodynamics PKPD of a Single Dose of GZR18 Injection in ObeseOverweight Subjects
Status:
COMPLETED
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a randomized double-blind placebo-controlled dose-escalation phase I clinical study A sequential design is used in this trial with a single dose escalation climb test to investigate the safety tolerability and PKPD characteristics of GZR18 injection in Chinese obeseoverweight subjects
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None